Paolini Rossella, Molfetta Rosa, Beitz Laurie O, Zhang Juan, Scharenberg Andrew M, Piccoli Mario, Frati Luigi, Siraganian Reuben, Santoni Angela
Department of Experimental Medicine and Pathology, Institute Pasteur-Fondazione Cenci Bolognetti, University La Sapienza, Rome 00161, Italy.
J Biol Chem. 2002 Oct 4;277(40):36940-7. doi: 10.1074/jbc.M204948200. Epub 2002 Jul 26.
Engagement of the high affinity receptor for IgE (FcepsilonRI) on mast cells and basophils results in FcepsilonRI beta and gamma subunits ubiquitination by an as yet undefined mechanism. Here we show that, upon FcepsilonRI engagement on RBL-2H3 cells Syk undergoes ubiquitination and Syk kinase activity is required for its own ubiquitination and that of FcepsilonRI beta and gamma chains. This requirement was demonstrated by overexpression of Syk wild-type or its kinase-dead mutant in RBL cells or using an Syk-deficient RBL-derived cell line transfected with wild-type or a kinase inactive form of Syk. We also identify c-Cbl as the E3 ligase responsible for both Syk and receptor ubiquitination. Furthermore, we demonstrate that Syk controls tyrosine phosphorylation of Syk-associated Cbl induced after receptor engagement. These data suggest a mutual regulation between Syk and Cbl activities. Finally, we show that a selective inhibitor of proteasome degradation induces persistence of tyrosine-phosphorylated receptor complexes, of activated Syk, and of FcepsilonRI-triggered degranulation. Our results provide a molecular mechanism for down-regulation of engaged receptor complexes by targeting ubiquitinated FcepsilonRI and activated Syk to the proteasome for degradation.
肥大细胞和嗜碱性粒细胞上IgE高亲和力受体(FcepsilonRI)的激活,通过一种尚未明确的机制导致FcepsilonRIβ和γ亚基发生泛素化。在此我们表明,在RBL-2H3细胞上激活FcepsilonRI后,Syk会发生泛素化,且Syk激酶活性对于其自身的泛素化以及FcepsilonRIβ和γ链的泛素化是必需的。在RBL细胞中过表达Syk野生型或其激酶失活突变体,或使用转染了野生型或激酶无活性形式Syk的RBL衍生的Syk缺陷细胞系,都证明了这一需求。我们还确定c-Cbl是负责Syk和受体泛素化的E3连接酶。此外,我们证明Syk控制受体激活后诱导的Syk相关Cbl的酪氨酸磷酸化。这些数据表明Syk和Cbl活性之间存在相互调节。最后,我们表明蛋白酶体降解的选择性抑制剂会导致酪氨酸磷酸化受体复合物、活化的Syk以及FcepsilonRI触发的脱颗粒持续存在。我们的结果提供了一种分子机制,通过将泛素化的FcepsilonRI和活化的Syk靶向蛋白酶体进行降解,来下调激活的受体复合物。